Cellebrite DI (CLBT) Long-Term Investments (2022 - 2025)

Cellebrite DI's Long-Term Investments history runs 4 years deep, the most recent figure standing at $98.0 million for Q4 2025.

• On a quarterly basis, Long-Term Investments rose 167.64% year-over-year to $98.0 million in Q4 2025; TTM through Dec 2025 was $98.0 million, a 167.64% increase from a year earlier, with the FY2025 full-year figure at $98.0 million, up 167.64% from the prior year.
• Long-Term Investments retreated to $98.0 million in Q4 2025 per CLBT's latest filing, from $117.1 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $146.9 million in Q2 2025 and bottomed at $22.1 million in Q4 2022.
• The 4-year median for Long-Term Investments is $53.3 million (2023), against an average of $67.2 million.
• Across the five-year window, Long-Term Investments gained 6.69% in 2023 and soared 167.64% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $22.1 million in 2022, then jumped by 30.44% to $28.9 million in 2023, then increased by 26.83% to $36.6 million in 2024, then surged by 167.64% to $98.0 million in 2025.
• Per Business Quant, the three latest CLBT Long-Term Investments figures stand at $98.0 million (Q4 2025), $117.1 million (Q3 2025), and $146.9 million (Q2 2025).